Alessandro Didonna University of California, San Francisco
51 protocols

Anca Savulescu University of Cape Town
23 protocols

Olga Kopach Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, University College London, UK
2 protocols

Pooja Teotia University of Nebraska Medical Center
1 protocol

Doyel Sen
  • Research scientist, E-Scape Bio Inc
Research focus
  • Biochemistry
  • Neurodegenerative disorders, Assay Development, Drug screening


PhD, Rutgers, 2012

2 Protocols reviewed
A Parkinson’s Disease-relevant Mitochondrial and Neuronal Morphology High-throughput Screening Assay in LUHMES Cells

Parkinson’s disease is a devastating neurodegenerative disorder affecting 2-3% of the population over 65 years of age. There is currently no disease-modifying treatment. One of the predominant pathological features of Parkinson’s disease

More >
Inositol Phosphates Purification Using Titanium Dioxide Beads
Authors:  Miranda SC Wilson and Adolfo Saiardi, date: 08/05/2018, view: 3877, Q&A: 0
Inositol phosphates (IPs) comprise a family of ubiquitous eukaryotic signaling molecules. They have been linked to the regulation of a pleiotropy of important cellular activities, but low abundance and detection difficulties have hampered our ...
More >
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.